Patheon BV
Patheon BV, a leading contract development and manufacturing organisation (CDMO), is headquartered in the United States and operates extensively across Europe and Asia. Founded in 1974, Patheon has established itself as a key player in the pharmaceutical and biotechnology industries, specialising in drug development, manufacturing, and delivery solutions.
The company offers a comprehensive range of services, including formulation development, clinical trial manufacturing, and commercial production, distinguished by its commitment to quality and innovation. Patheon’s state-of-the-art facilities and advanced technologies enable it to meet the diverse needs of its clients, ensuring efficient and reliable product delivery.
With a strong market position, Patheon BV has achieved notable milestones, including strategic partnerships and expansions that enhance its global footprint. Its dedication to excellence has solidified its reputation as a trusted partner for pharmaceutical companies seeking to bring life-saving therapies to market.
+35 vs industry average
Patheon BV’s score of 75 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Patheon BV?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Patheon BV yet.
Patheon BV's reported carbon emissions
Patheon BV, headquartered in the US, currently does not have available carbon emissions data for the most recent year. As a current subsidiary of Thermo Fisher Scientific Inc., any potential emissions data or climate commitments would be cascaded from this parent organisation.
Patheon BV has not specified any reduction targets or climate pledges in its own right. However, it is important to note that as part of Thermo Fisher Scientific Inc., it may align with broader corporate sustainability initiatives and commitments, including those related to the Science Based Targets initiative (SBTi) and other climate action frameworks.
Without specific emissions data or reduction targets, it is challenging to provide a detailed overview of Patheon BV's carbon footprint or climate commitments. The company may still be engaged in sustainability efforts as part of its corporate family, but further information would be required to assess its individual impact and commitments accurately.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Patheon BV’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Patheon BV yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Thermo Fisher Scientific Inc.
Carbon Disclosure Project
Inherited from Thermo Fisher Scientific Inc.The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Thermo Fisher Scientific Inc.RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Patheon BV yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project